Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22198309 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients
Conditions: Gastrointestinal Stromal Tumors,;   Cancer,;   Solid Tumors
Interventions: Drug: Peginterferon-alpha 2b (PegIFNa2b);;   Drug: Imatinib

Indicates status has not been verified in more than two years